Literature DB >> 25429980

Acetaminophen/paracetamol: A history of errors, failures and false decisions.

K Brune1, B Renner1, G Tiegs2.   

Abstract

Acetaminophen/paracetamol is the most widely used drug of the world. At the same time, it is probably one of the most dangerous compounds in medical use, causing hundreds of deaths in all industrialized countries due to acute liver failure (ALF). Publications of the last 130 years found in the usual databases were analyzed. Personal contacts existed to renowned researchers having contributed to the medical use of paracetamol and its precursors as H.U. Zollinger, S. Moeschlin, U. Dubach, J. Axelrod and others. Further information is found in earlier reviews by Eichengrün, Rodnan and Benedek, Sneader, Brune; comp. references. The history of the discovery of paracetamol starts with an error (active against worms), continues with a false assumption (paracetamol is safer than phenacetin), describes the first side-effect 'epidemy' (phenacetin nephropathy, drug-induced interstitial nephritis) and ends with the discovery of second-generation problems due to the unavoidable production of a highly toxic metabolite of paracetamol N-acetyl-p-benzoquinone imine (NAPQI) that may cause not only ALF and kidney damage but also impaired development of the fetus and the newborn child. It appears timely to reassess the risk/benefit ratio of this compound.
© 2014 European Pain Federation - EFIC®

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25429980     DOI: 10.1002/ejp.621

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  32 in total

Review 1.  Oral paracetamol (acetaminophen) for cancer pain.

Authors:  Philip J Wiffen; Sheena Derry; R Andrew Moore; Ewan D McNicol; Rae F Bell; Daniel B Carr; Mairead McIntyre; Bee Wee
Journal:  Cochrane Database Syst Rev       Date:  2017-07-12

2.  Sodium 4-phenylbutyric acid prevents murine acetaminophen hepatotoxicity by minimizing endoplasmic reticulum stress.

Authors:  Hiromi Kusama; Kazuyoshi Kon; Kenichi Ikejima; Kumiko Arai; Tomonori Aoyama; Akira Uchiyama; Shunhei Yamashina; Sumio Watanabe
Journal:  J Gastroenterol       Date:  2016-09-06       Impact factor: 7.527

Review 3.  [Considerations concerning the perioperative use of metamizole].

Authors:  R Sittl; P Bäumler; A-M Stumvoll; D Irnich; B Zwißler
Journal:  Anaesthesist       Date:  2019-08       Impact factor: 1.041

4.  Prophylactic Low-Dose Paracetamol Administration for Ductal Closure and Amplitude-Integrated Electroencephalography in Preterm Infants.

Authors:  Christina Schreiner; Maria Sappler; Michaela Höck; Marlene Hammerl; Vera Neubauer; Ursula Kiechl-Kohlendorfer; Elke Griesmaier
Journal:  Front Pediatr       Date:  2022-05-23       Impact factor: 3.569

Review 5.  Psychedelics in the Treatment of Headache and Chronic Pain Disorders.

Authors:  Emmanuelle A D Schindler
Journal:  Curr Top Behav Neurosci       Date:  2022

6.  Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization.

Authors:  Daiany P B da Silva; Iziara F Florentino; Dayane M da Silva; Roberta C Lino; Carina S Cardoso; Lorrane K S Moreira; Géssica A Vasconcelos; Daniela C Vinhal; Anna C D Cardoso; Bianca Villavicencio; Hugo Verli; Boniek G Vaz; Luciano M Lião; Luiz C da Cunha; Ricardo Menegatti; Elson A Costa
Journal:  Inflammopharmacology       Date:  2018-07-23       Impact factor: 4.473

7.  Analgesic Drug Prescription Patterns on Five International Paediatric Wards.

Authors:  Sebastian Botzenhardt; Asia N Rashed; Ian C K Wong; Stephen Tomlin; Antje Neubert
Journal:  Paediatr Drugs       Date:  2016-12       Impact factor: 3.022

Review 8.  Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1.

Authors:  P S S Rao; Narasimha M Midde; Duane D Miller; Subhash Chauhan; Anil Kumar; Santosh Kumar
Journal:  Curr Drug Metab       Date:  2015       Impact factor: 3.731

9.  Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and Self-Reported Outcomes.

Authors:  Kosuke Inoue; Beate Ritz; Andreas Ernst; Wan-Ling Tseng; Yuying Yuan; Qi Meng; Cecilia Høst Ramlau-Hansen; Katrine Strandberg-Larsen; Onyebuchi A Arah; Carsten Obel; Jiong Li; Jørn Olsen; Zeyan Liew
Journal:  Am J Epidemiol       Date:  2021-06-01       Impact factor: 4.897

Review 10.  STAT3, a Key Parameter of Cytokine-Driven Tissue Protection during Sterile Inflammation - the Case of Experimental Acetaminophen (Paracetamol)-Induced Liver Damage.

Authors:  Heiko Mühl
Journal:  Front Immunol       Date:  2016-05-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.